These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1822109)

  • 1. Rheumatoid arthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials of antirheumatic drugs.
    Bellamy N; Anastassiades TP; Buchanan WW; Davis P; Lee P; McCain GA; Wells GA; Campbell J
    J Rheumatol; 1991 Dec; 18(12):1901-7. PubMed ID: 1822109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ankylosing spondylitis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials.
    Bellamy N; Buchanan WW; Esdaile JM; Fam AG; Kean WF; Thompson JM; Wells GA; Campbell J
    J Rheumatol; 1991 Nov; 18(11):1709-15. PubMed ID: 1787493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoarthritis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials.
    Bellamy N; Carette S; Ford PM; Kean WF; le Riche NG; Lussier A; Wells GA; Campbell J
    J Rheumatol; 1992 Mar; 19(3):444-50. PubMed ID: 1578461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid arthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.
    Bellamy N; Anastassiades TP; Buchanan WW; Davis P; Lee P; McCain GA; Wells GA; Campbell J
    J Rheumatol; 1991 Dec; 18(12):1893-900. PubMed ID: 1795329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid arthritis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise.
    Bellamy N; Anastassiades TP; Buchanan WW; Davis P; Lee P; McCain GA; Wells GA; Campbell J
    J Rheumatol; 1991 Dec; 18(12):1908-15. PubMed ID: 1795330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ankylosing spondylitis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise.
    Bellamy N; Buchanan WW; Esdaile JM; Fam AG; Kean WF; Thompson JM; Wells GA; Campbell J
    J Rheumatol; 1991 Nov; 18(11):1716-22. PubMed ID: 1787494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoarthritis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.
    Bellamy N; Carette S; Ford PM; Kean WF; le Riche NG; Lussier A; Wells GA; Campbell J
    J Rheumatol; 1992 Mar; 19(3):436-43. PubMed ID: 1578460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures.
    Bellamy N; Buchanan WW; Esdaile JM; Fam AG; Kean WF; Thompson JM; Wells GA; Campbell J
    J Rheumatol; 1991 Nov; 18(11):1701-8. PubMed ID: 1787492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA; Bingham CO
    Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoarthritis antirheumatic drug trials. III. Setting the delta for clinical trials--results of a consensus development (Delphi) exercise.
    Bellamy N; Carette S; Ford PM; Kean WF; le Riche NG; Lussier A; Wells GA; Campbell J
    J Rheumatol; 1992 Mar; 19(3):451-7. PubMed ID: 1578462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid arthritis. Outcome measures.
    Paulus HE; Bulpitt KJ
    Rheum Dis Clin North Am; 1995 Aug; 21(3):605-18. PubMed ID: 8619091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A proposed revision to the ACR20: the hybrid measure of American College of Rheumatology response.
    American College of Rheumatology Committee to Reevaluate Improvement Criteria
    Arthritis Rheum; 2007 Mar; 57(2):193-202. PubMed ID: 17330293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritis.
    Farahani P; Levine M; Gaebel K; Thabane L
    Can J Clin Pharmacol; 2005; 12(3):e254-63. PubMed ID: 16278497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of rheumatoid arthritis clinical trial outcome measures: a simulation study.
    Anderson JJ; Bolognese JA; Felson DT
    Arthritis Rheum; 2003 Nov; 48(11):3031-8. PubMed ID: 14613263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of MRI in rheumatoid arthritis: research and clinical issues.
    Freeston JE; Bird P; Conaghan PG
    Curr Opin Rheumatol; 2009 Mar; 21(2):95-101. PubMed ID: 19339918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Nijmegen inception cohort of early rheumatoid arthritis.
    Welsing PM; van Riel PL
    J Rheumatol Suppl; 2004 Mar; 69():14-21. PubMed ID: 15053447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic monitoring of disease activity using an outcome measure improves outcomes in rheumatoid arthritis.
    Katchamart W; Bombardier C
    J Rheumatol; 2010 Jul; 37(7):1411-5. PubMed ID: 20436069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid arthritis: disease-modifying antirheumatic drugs.
    Kirwan JR; Currey HL
    Clin Rheum Dis; 1983 Dec; 9(3):581-99. PubMed ID: 6360514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.
    Aletaha D; Landewe R; Karonitsch T; Bathon J; Boers M; Bombardier C; Bombardieri S; Choi H; Combe B; Dougados M; Emery P; Gomez-Reino J; Keystone E; Koch G; Kvien TK; Martin-Mola E; Matucci-Cerinic M; Michaud K; O'Dell J; Paulus H; Pincus T; Richards P; Simon L; Siegel J; Smolen JS; Sokka T; Strand V; Tugwell P; van der Heijde D; van Riel P; Vlad S; van Vollenhoven R; Ward M; Weinblatt M; Wells G; White B; Wolfe F; Zhang B; Zink A; Felson D
    Ann Rheum Dis; 2008 Oct; 67(10):1360-4. PubMed ID: 18791055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long acting drug combinations in rheumatoid arthritis: a formal overview.
    Boers M; Ramsden M
    J Rheumatol; 1991 Mar; 18(3):316-24. PubMed ID: 1856802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.